This analysis of survey data finds that over 40% of adults under 65 with private insurance could be indicated for a GLP-1 drug though relatively few have a claim, suggesting that a much smaller share seeks treatment through healthcare providers.| Peterson-KFF Health System Tracker
Although most adults are in good health and have health insurance, more than 1 in 4 adults (28%) reported delaying or foregoing healthcare due to cost.| Peterson-KFF Health System Tracker